Efficacy, Immunogenicity and Safety of Inactivated Vaccine (Coronavac) Against SARS-COV2 in Children and Adolescents
Clinical trial NCT05225285 · UNKNOWN
Trial details
- NCT number
- NCT05225285
- Sponsor
- Federal University of Espirito Santo
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-21
- Primary completion
- 2022-06-21
- Enrollment
- 1120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.